Bank of New York Mellon Corp - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 82 filers reported holding REPROS THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$24,000
+242.9%
36,983
+69.9%
0.00%
Q3 2017$7,000
-30.0%
21,7730.0%0.00%
Q2 2017$10,000
-63.0%
21,773
-3.0%
0.00%
Q1 2017$27,000
-6.9%
22,446
+3.1%
0.00%
Q4 2016$29,000
-39.6%
21,773
-6.1%
0.00%
Q3 2016$48,000
+9.1%
23,176
-14.8%
0.00%
Q2 2016$44,000
+69.2%
27,1990.0%0.00%
Q1 2016$26,000
-21.2%
27,1990.0%0.00%
Q4 2015$33,000
-91.8%
27,199
-49.6%
0.00%
Q3 2015$401,000
+17.3%
54,010
+12.7%
0.00%
Q2 2015$342,000
-72.6%
47,917
-67.0%
0.00%
Q1 2015$1,246,000
-6.5%
145,131
+8.6%
0.00%
Q4 2014$1,332,000
+6.6%
133,578
+5.8%
0.00%
Q3 2014$1,249,000
-69.1%
126,205
-46.0%
0.00%
-100.0%
Q2 2014$4,040,000
+85.2%
233,592
+90.0%
0.00%0.0%
Q1 2014$2,182,000
-2.0%
122,964
+1.0%
0.00%0.0%
Q4 2013$2,227,000
-70.0%
121,714
-56.1%
0.00%0.0%
Q3 2013$7,422,000
+301.6%
276,950
+176.4%
0.00%0.0%
Q2 2013$1,848,000100,2040.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,132,367$11,210,0004.33%
DESTRIER CAPITAL MANAGEMENT LLC 933,600$9,243,0002.32%
SENZAR ASSET MANAGEMENT, LLC 753,600$7,460,0002.19%
ORACLE INVESTMENT MANAGEMENT INC 1,014,164$10,040,0001.39%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 775,307$7,675,0000.50%
Trellus Management Company, LLC 50,000$495,0000.42%
FNY Managed Accounts LLC 14,000$138,600,0000.42%
GENERAL AMERICAN INVESTORS CO INC 449,475$4,450,0000.36%
Baker Brothers Advisors 2,778,654$27,509,0000.35%
CQS Cayman LP 550,000$5,445,0000.32%
View complete list of REPROS THERAPEUTICS INC shareholders